116 related articles for article (PubMed ID: 9809926)
1. Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1201-6. PubMed ID: 9809926
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1194-200. PubMed ID: 9809925
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Circulation; 1997 Oct; 96(8):2545-50. PubMed ID: 9355892
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 May; 31(6):1323-9. PubMed ID: 9581727
[TBL] [Abstract][Full Text] [Related]
5. [Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance].
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Cardiol; 1998 Mar; 31(3):173-81. PubMed ID: 9557281
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 May; 62(5):353-8. PubMed ID: 9626903
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Circulation; 1998 Mar; 97(9):886-91. PubMed ID: 9521337
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of carvedilol attenuates nitrate tolerance by preventing cytochrome p450 depletion.
Nakahira A; Minamiyama Y; Takemura S; Hirai H; Sasaki Y; Okada S; Funae Y; Suehiro S
Circ J; 2010 Aug; 74(8):1711-7. PubMed ID: 20574135
[TBL] [Abstract][Full Text] [Related]
10. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
Morgan T; Snowden R; Butcher L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to nitrates with enhanced radical formation suppressed by carvedilol.
Fink B; Schwemmer M; Fink N; Bassenge E
J Cardiovasc Pharmacol; 1999 Dec; 34(6):800-5. PubMed ID: 10598122
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
13. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol.
Fraga R; Franco FG; Roveda F; de Matos LN; Braga AM; Rondon MU; Rotta DR; Brum PC; Barretto AC; Middlekauff HR; Negrão CE
Eur J Heart Fail; 2007; 9(6-7):630-6. PubMed ID: 17475552
[TBL] [Abstract][Full Text] [Related]
14. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate.
McVeigh GE; Hamilton P; Wilson M; Hanratty CG; Leahey WJ; Devine AB; Morgan DG; Dixon LJ; McGrath LT
Circulation; 2002 Jul; 106(2):208-13. PubMed ID: 12105160
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
19. Evidences for prevention of nitroglycerin tolerance by carvedilol.
El-Demerdash E
Pharmacol Res; 2006 Apr; 53(4):380-5. PubMed ID: 16503407
[TBL] [Abstract][Full Text] [Related]
20. No evidence of nitrate tolerance caused by nebivolol.
Stoschitzky K; Stoschitzky G; Pieske B; Wascher T
Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):40-4. PubMed ID: 24532547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
